Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-03-14 @ 5:31 AM
Study NCT ID:
NCT04241120
Status:
COMPLETED
Last Update Posted:
2023-03-27
First Post:
2020-01-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Feasibility Study for Treating Trichotillomania With Wearable Device and App System
Sponsor:
HabitAware Inc.
Organization:
Study Overview
Official Title:
Feasibility Study for Treating Trichotillomania With Wearable Device and App System Using Habit Reversal Training
Status:
COMPLETED
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Trichotillomania is characterized by recurrent hair pulling resulting in hair loss causing significant distress and impairment which persists despite repeated attempts to stop. Behavioral based therapies focused on increasing awareness of hair pulling followed by the use of an incompatible behavior have proven effective. In an effort to enhance awareness, a wrist worn motion detection device was created. In this study, we will test the feasibility of the HabitAware device and accompanying app as a system for delivering self-administered habit reversal training (HRT).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| R43MH114773 | NIH | None | https://reporter.nih.gov/quic… | View |